How Will Skyrizi and Rinvoq Shape AbbVie's Q1 Immunology Sales? | Collector
Quartz
How Will Skyrizi and Rinvoq Shape AbbVie's Q1 Immunology Sales?
ABBV heads into Q1 earnings with Skyrizi and Rinvoq in focus as Humira declines, while growth from new indications and market share gains is under watch.
Quartz